ISOVUE-370 Drug Patent Profile
✉ Email this page to a colleague
When do Isovue-370 patents expire, and when can generic versions of Isovue-370 launch?
Isovue-370 is a drug marketed by Bracco and is included in two NDAs.
The generic ingredient in ISOVUE-370 is iopamidol. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iopamidol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isovue-370
A generic version of ISOVUE-370 was approved as iopamidol by HAINAN POLY on February 27th, 2023.
Summary for ISOVUE-370
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Clinical Trials: | 20 |
Patent Applications: | 3,484 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ISOVUE-370 |
DailyMed Link: | ISOVUE-370 at DailyMed |
Recent Clinical Trials for ISOVUE-370
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
NYU Langone Health | N/A |
M.D. Anderson Cancer Center | N/A |
National Cancer Institute (NCI) | N/A |
Pharmacology for ISOVUE-370
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for ISOVUE-370
US Patents and Regulatory Information for ISOVUE-370
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | ISOVUE-370 | iopamidol | INJECTABLE;INJECTION | 018735-003 | Dec 31, 1985 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bracco | ISOVUE-370 | iopamidol | INJECTABLE;INJECTION | 020327-004 | Oct 12, 1994 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ISOVUE-370
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | ISOVUE-370 | iopamidol | INJECTABLE;INJECTION | 018735-003 | Dec 31, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Bracco | ISOVUE-370 | iopamidol | INJECTABLE;INJECTION | 020327-004 | Oct 12, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ISOVUE-370
See the table below for patents covering ISOVUE-370 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Philippines | 12321 | WATER-SOLUBLE,NON-IONIXING DERIVATIVES OF 2,4,6-TRIIODO-ISOPHTHALIC ACID | ⤷ Try a Trial |
Denmark | 567475 | ⤷ Try a Trial | |
Germany | 2547789 | 5-HYDROXYPROPIONYLAMINO-2,4,6-TRIJOD- ISOPHTHALSAEURE-BIS-(DIHYDROXYPROPYLAMIDE) VERFAHREN ZU IHRER HERSTELLUNG UND DIESE ENTHALTENDE ROENTGENKONTRASTMITTEL | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |